Table 3.
Stratification | Death | |||
---|---|---|---|---|
Variable | Variable | HRa | 95% CIb | p-value |
Low BRCA1 | T cell activation | |||
Exhaustion | 1.00 | |||
Intermediate | 0.47 | 0.28–0.80 | 0.006 | |
Activation | 0.43 | 0.20–0.93 | 0.031 | |
p-trend | 0.011 | |||
Age (per 5 years) | 1.15 | 1.05–1.27 | 0.004 | |
Disease Stage | 2.78 | 1.89–4.10 | < 0.0001 | |
Histological type | ||||
Ductal | 1.00 | |||
Lobular | 0.54 | 0.29–1.00 | 0.048 | |
Mix | 0.81 | 0.29–2.28 | 0.683 | |
Other | 2.36 | 0.92–6.03 | 0.074 | |
High BRCA1 | T cell activation | |||
Exhaustion | 1.00 | |||
Intermediate | 1.47 | 0.85–2.55 | 0.174 | |
Activation | 0.53 | 0.20–1.43 | 0.211 | |
p-trend | 0.640 | |||
Age (per 5 years) | 1.23 | 1.13–1.35 | < 0.0001 | |
Disease Stage | 2.07 | 1.45–2.96 | < 0.0001 | |
Histological type | ||||
Ductal | 1.00 | |||
Lobular | 0.77 | 0.39–1.52 | 0.448 | |
Mix | 0.68 | 0.25–1.87 | 0.450 | |
Other | 2.79 | 1.09–7.13 | 0.032 | |
P-value for the interaction between BRCA1 level and T cell activation | 0.009 |
aHR: adjusted hazard ratio, which was obtained from a multivariate Cox proportional hazards regression model
bCI confidence interval